In a technical report published today, ECDC, proposes a targeted testing approach in areas with ongoing avian influenza outbreaks in poultry and detections in wild birds and other animals, focusing on severe respiratory or unexplained neurological disease.
Today ECDC is providing an update on the current status of COVID-19 transmission in the European Union and European Economic Area (EU/EEA), the emergence of new SARS-CoV-2 variants, and public health considerations for Autumn 2023.
In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.
The new joint report by ECDC and Eurofound concludes that adult work-life balance was significantly affected by measures such as stay-at-home orders and recommendations.
Since 2022, and as of 17 July 2023, 19 neonates with severe Echovirus 11 (E11) infection have been reported in the EU/EEA, by France, Croatia, Sweden, Spain, and Italy, and nine of these neonates have died.
The European Union Aviation Safety Agency (EASA) and the European Centre for Disease Prevention and Control (ECDC) have decided to formally retire the EASA-ECDC joint Aviation Health Safety Protocol (AHSP), while acknowledging its significant value during the high SARS-CoV-2 circulation periods during the pandemic.
ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.